We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies.

PharmaLogic is paying an undisclosed sum to pick up a majority stake in Norway’s Agilera Pharma. The move forms part of the CDMO’s strategy to position itself as the industry's first global ...

Norway is building the world’s longest and deepest underwater tunnel, one of Europe’s most ambitious engineering projects which is hoped will boost the country’s transport links and ...

Credit : Shutterstock, Gints Ivuskans With global trade tensions on the rise and the US tightening tariffs, Norway is stepping up efforts to strengthen its ties with the European Union — despite still ...

Norway, famously known as "The Land of the Midnight Sun", experiences a natural phenomenon where the sun doesn’t set for weeks during summer and doesn’t rise for weeks in winter. This is due ...

File Photo by Harris & Ewing/Library of Congress In 1940, Germany invaded Norway and Denmark. Nazi Propaganda Minister Joseph Goebbels blamed Britain for the invasion, accusing the Allies of ...

Norway has reported the lowest rate of Campylobacter positive broiler flocks since 2009. In 2024, 70 out of more than 2,000 broiler flocks tested positive for Campylobacter as part of a food ...

As young as 10 years old, he impressed viewers and judges on the TV show Norway’s Got Talent, earning a ‘golden buzzer’ on his first audition and going straight to the final. Kyle, who is half Spanish ...

The FDA accepted the resubmission of the BLA for ONS-5010, classifying it as a Class 2 review with a PDUFA date of August 27, 2025. The resubmission follows a complete response letter citing CMC ...

‘Your planned departure from Norway and the Schengen area is 1 March 2025, and the passport is not valid for three months after the date of departure as the border regulation demands.

The FDA set a Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025. ONS-5010, if approved, will be branded as LYTENAVA™ (bevacizumab-vikg) in the United States for the treatment ...